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I. Introduction 
Molly Rose Nash was born in Colorado, on July 4, 1994.1 While 
the birth of a child is usually remembered joyously, it was 
immediately obvious that something was wrong with Molly, as she 
was only able to emit a “sickly whimper.”2 Doctors soon realized 
that Molly had been born with a genetic condition known as 
Fanconi Anemia.3 Fanconi Anemia is an extremely rare genetic 
condition, resulting from a genetic defect in the proteins 
responsible for DNA repair.4 The condition meant that Molly’s 
body was unable to produce sufficient blood cells.5 Fanconi Anemia 
results in a myriad of problems, ranging from an extremely high 
likelihood of developing acute myelogenous leukemia, to an over 
90% chance of developing bone marrow failure.6 People with 
Fanconi Anemia who manage to survive early childhood have a 
high incidence of esophageal, head and neck, gastrointestinal, and 
anal cancers.7 While there are treatments that can help delay bone 
marrow failure, the only cure is a bone marrow transplant,8 which 
is best provided by a sibling who is a match.9 Unfortunately, Molly 
was an only child.10 While the Nash family originally wanted to 
                                                                                                     
 1. Amanda M. Faison, The Miracle of Molly, 5280 (Aug. 2005), http://www. 
5280.com/2005/08/the-miracle-of-molly/ (on file with the Washington & Lee 
Journal of Civil Rights & Social Justice). 
 2. Id. 
 3. Id. 
 4. See Alan D. D‘Andrea, Susceptibility Pathways in Fanconi‘s Anemia and 
Breast Cancer, 362 NEW ENG. J. MEDICINE 1909, 1909–11 (2010) (explaining the 
cause of Fanconi’s Anemia and its rarity). 
 5. See Faison, supra note 1 (stating that Fanconi Anemia caused Molly to 
have an insufficient number of blood cells). 
 6. See D’Andrea, supra note 4, at 1910 (listing the symptoms and 
complications that come with Fanconi’s Anemia).  
 7. See id. (specifying the other types of cancer that can result from 
Fanconi’s Anemia). 
 8. See Faison, supra note 1 (“A bone marrow transplant . . . is the only cure 
for progressive bone marrow failure.”); see also D’Andrea, supra note 4 (stating 
that a bone marrow transplant is a viable treatment for Fanconi’s Anemia). 
 9. See HLA Matching, NAT’L MARROW DONOR PROGRAM, https://bethe 
match.org/patients-and-families/before-transplant/find-a-donor/hla-matching/ 
(last visited Apr. 17, 2018) (noting that the best bone marrow donations are from 
siblings) (on file with the Washington & Lee Journal of Civil Rights & Social 
Justice). 
 10. Faison, supra note 1. 
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have more children, Fanconi Anemia is an inherited condition,11 
and once Molly was diagnosed, they knew they were both healthy 
carriers of the genes for the disease.12 This meant that any 
additional children they had could suffer the same disease as 
Molly.13  
There seemed to be no hope for the family, until doctors 
proposed a combination of pre-implantation genetic diagnosis 
(PGD) and in vitro-fertilization (IVF) that would lead to a novel 
concept in the field of biomedicine: that of the savior sibling.14 
Using these techniques, the physicians were able to harvest ova 
and collect sperm from the Nashes, combine them in the 
laboratory, and then use PGD to screen the embryo, to ensure that 
it did not carry the Fanconi Anemia gene.15 After four in vitro 
fertilization attempts, Lisa Nash gave birth to a baby boy, named 
Adam.16 Adam’s placenta was gathered immediately and the 
umbilical cord blood was saved.17 Umbilical cord blood contains 
stem cells that doctors then transplanted into Molly’s circulatory 
system.18
 
After four weeks, Molly showed bone marrow recovery 
and three years later, her immune system was normal.19 The 
popular media termed Adam a “savior sibling,” as he was born with 
a unique purpose: to save his older sister.20  
                                                                                                     
 11. Giuseppe Burgio et al., Conceiving a Hematopoietic Stem Cell Donor: 
Twenty-Five Years After our Decision to Save a Child, 97 HAEMATOLOGICA 479, 
479–81 (2012). 
 12. Faison, supra note 1. 
 13. See id. (“And because both [of Molly’s parents] are carriers for the 
disease, there was a whopping 25 percent chance they would have a baby with 
[Franconi’s Anemia].”). 
 14. See Satkiran Grewal et al., Successful Hematopoietic Stem Cell 
Transplantation for Fanconi Anemia from An Unaffected HLA-Genotype–
Identical Sibling Selected Using Preimplantation Genetic Diagnosis, 103 BLOOD 
1147, 1147, 1150 (2004) (discussing the novelty of “savior siblings” and how it was 
Molly’s only viable option). 
 15. See id. at 1147–48 (describing the process to create a “savior sibling”). 
 16. Faison, supra note 1. 
 17. Id. 
 18. See id. (explaining that umbilical cord blood contains stem cells that are 
required to heal Molly). 
 19. Bruce Dickens, Preimplantation Genetic Diagnosis and ‘Savior Siblings’, 
88 INT’L J. GYNECOLOGY & OBSTETRICS 91, 94 (2005). 
 20. See Kirsty Horsey, US ‘Saviour Siblings’ Spark Debate, IVF.NET (May 5, 
2004), https://ivf.net/ivf/us-saviour-siblings-spark-debate-o299.html (naming the 
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As the Nash family can attest, advances in reproductive 
technology are increasingly finding applications in fields that seem 
more the realm of science fiction than reality.21 One such 
application is in the treatment of individuals suffering with rare 
genetic diseases, who are desperately in need of some form of 
biological material transplantation.22  
“Savior siblings” is the term used to describe a sibling created 
for the purpose of providing biological material that can help treat 
or cure an existing terminally ill child.23 These children are 
conceived through the sequential use of two reproductive 
technologies: pre-implantation genetic diagnosis (PGD) and in-
vitro fertilization (IVF).24 While these techniques were developed 
for other purposes, in the context of savior siblings, PGD is used to 
screen embryos prior to implantation in the uterus, to determine 
whether the embryo will be a tissue “match” to a sick child.25 It is 
estimated that roughly one percent of PGD in the United States is 
used to create children that are tissue matches for their siblings.26 
While the process has become more common in America in 
recent years, meaningful discussion about savior siblings has 
lagged. The practice has advanced with nearly no governmental 
involvement, as there exists no formal regulation or professional 
society guidelines governing the use or creation of savior siblings.27 
                                                                                                     
first savior sibling “Adam”) (on file with the Washington & Lee Journal of Civil 
Rights & Social Justice). 
 21. See Alison Motluk, Fertility Treatments: From Sci-Fi to Reality, GLOBE & 
MAIL (Feb. 9, 2015), https://www.theglobeandmail.com/life/health-and-fitness/hea 
lth/a-look-inside-the-changing-world-of-fertility/article22863038/ (describing how 
advanced reproductive technology is today) (on file with the Washington & Lee 
Journal of Civil Rights & Social Justice). 
 22. See Horsey, supra note 20 (explaining that tissue transplants from 
“savior siblings” had been used to treat several types of leukemia and anemia). 
 23. See id. (noting that “savior siblings” are used to help treat terminally ill 
siblings via biological donations). 
 24. See Faison, supra note 1 (describing the process by which “savior 
siblings” are conceived). 
 25. See id. (explaining how PGD is used to screen embryos for a specific 
tissue match). 
 26. See BETH WHITEHOUSE, S ’AMILYFNE OIBLINGS AND SAVIOR S :ATCHMHE T
BATTLE TO HEAL THEIR DAUGHTER 127 (2001) (stating the percent of PGD uses 
that correspond with “savior siblings”).  
 27. See Michelle J. Bayefsky, Comparative Preimplantation Genetic 
Diagnosis Policy in Europe and the USA and Its Implications for Reproductive 
Tourism, 3 REPROD. BIOMEDICINE & SOC’Y ONLINE 41, 43–45 (2016) (discussing 
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The case of the United States stands in stark contrast to other 
countries, particularly the United Kingdom, where a robust 
regulatory framework for the use of savior siblings has risen, along 
with debate and discussion over the acceptability of savior 
siblings.28  
The issue of savior siblings is fraught with ethical pitfalls.29 
Thus, extraordinary care and planning must be invested to ensure 
that the process is undertaken only when absolutely necessary and 
is done in a way that respects the dignity of the new child.30 
Protection of dignity and preservation of autonomy are 
fundamental tenets in bioethics, and must be kept in mind, 
especially when dealing with a vulnerable population, such as 
children.31 Caution is paramount, as there is potential for serious 
ethical missteps. For instance, some hypothesize that the savior 
sibling may be irrevocably harmed by being a savior, if the child 
believes that they were not wanted for themselves, or if a child 
conceived for this reason enjoys a less close and loving relationship 
with his/her parents.32 Opponents of this practice go so far as to 
suggest that no matter how the parents choose to love and care for 
the new child, it still does not ameliorate the harm caused by the 
fact that this child may be aware that they were born for the 
purpose of saving their sibling.33 These potential harms contrast 
                                                                                                     
the lack of regulation regarding PGD in the United States). 
 28. See id. (comparing the regulation of the United Kingdom with the lack of 
regulation in the United States). 
 29. See Grewal et al., supra note 14 (listing several ethical issues regarding 
savior siblings). 
 30. See Thomas R. McCormick, Principles of Bioethics, UNIV. WASH. SCH. 
MED., https://depts. washington.edu/bioethx/tools/princpl.html (last updated Oct. 
1, 2013) (describing the “[f]our commonly accepted principles of health care 
ethics . . . include[ing] the: principal of respect for autonomy, . . . of 
nonmaleficence . . . of beneficence, and . . . justice” implicated by savior siblings) 
(on file with the Washington & Lee Journal of Civil Rights & Social Justice). 
 31. See Grewal et al., supra note 14 (describing ethical issues regarding 
savior siblings). 
 32. See Jennifer Lahl, My Sister’s Savior, CBC (July 22, 2009), http://www. 
cbc-network.org/2009/07/my-sisters-savior/ (describing the argument that savior 
siblings will be irrevocably harmed by being a savior sibling) (on file with the 
Washington & Lee Journal of Civil Rights & Social Justice). 
 33. See Alasdair Cochrane, Undignified Bioethics, 24 BIOETHICS 234, 235–38 
(2010) (stating the various arguments that dignity should play a major role in 
bioethics). 
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with the therapeutic benefits that having a savior sibling can 
provide, both for the existing sick child, who gets to continue living, 
and the family unit as a whole, who not only do not have to bury a 
child, but now have the enjoyment of two (hopefully healthy) 
children. Consideration of savior siblings is a necessary endeavor 
for those at the intersection of law and bioethics, as this process 
raises a number of issues that can benefit from the input of those 
with an understanding, not only of bioethical principles, but of 
legal issues concerning child autonomy, welfare, and pediatric 
consent.34  
This Article will approach the topic of savior siblings, created 
using pre-implantation genetic diagnosis and in-vitro fertilization, 
from an ethical and legal focus. It will start with an investigation 
into the nature and technology surrounding the creation of savior 
siblings. The next section will move into a discussion about the 
unique ethical issues presented by savior siblings. Then, the 
regulatory framework (or lack thereof) that governs their use will 
be addressed, contrasting the lack of regulation in the United 
States, with the framework in the United Kingdom, where the use 
of savior siblings is regulated. This Article will conclude with a 
series of practical recommendations, including a call for regulation 
in the United States, in order to move the field forward ethically, 
and responsibly. 
II. What is a savior sibling? 
Most of the conditions that savior siblings are used to 
ameliorate are genetic in nature.35 Pre-implantation genetic 
diagnosis (PGD) refers to the genetic profiling of embryos, and is 
used to screen embryos and zygotes for genetic diseases.36 In PGD, 
                                                                                                     
 34.  See generally Zachary E. Shapiro, FIELD NOTES: BIOETHICS IN THE LAW, 
47 HASTINGS CTR. REP. 1 (2017).  
 35. See Horsey, supra note 20 (explaining that savior siblings are used to 
help treat terminally ill siblings via biological donations). 
 36. See Molina B. Dayal et al., Preimplantation Genetic Diagnosis, 
MEDSCAPE, https://emedicine.medscape.com/article/273415-overview (last 
updated Dec. 30, 2015) (“[PGD] refers specifically to when one or both genetic 
parents has a known genetic abnormality and testing is performed on an embryo 
to determine if it also carries a genetic abnormality.”) (on file with the Washington 
& Lee Journal of Civil Rights & Social Justice). 
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a biopsy is taken from an embryo that has been artificially 
fertilized outside of a woman’s womb.37 This biopsy then undergoes 
genetic analysis, in order to determine genetic makeup of the 
embryo, with respect to the disorder in question.38 
Given that PGD requires a biopsy, it is an invasive procedure 
that carries small, but real, risks to the embryo.39 While most of 
the risks come from improper biopsy technique, the risks are real.40 
Most medical practitioners therefore feel that PGD is only 
warranted if there is a necessary indication for its use.41  
PGD is undertaken when creating a savior sibling for two 
reasons. First, it is important that the new child does not suffer 
the same disease as the existing child, as a sick child cannot serve 
as a donor, and could face the same health problem as their older 
sibling.42 Second, it is essential that the new sibling be a tissue (or 
HLA) match with their older sibling, so that the child can 
successfully donate biological material without fear of said 
material being rejected.43 Even close relatives and siblings are 
often not a genetic match, meaning they would be unable to donate 
biological material.44 When a donor is not a match, the recipient’s 
                                                                                                     
 37. Id. 
 38. See id. (explaining that in PGD the embryo is tested to determine if it is 
afflicted with a genetic disorder). 
 39. See Embryo Freezing (Cryopreservation), GENETICS IVF INST., 
http://www.givf.com/fertility/embryofreezing.shtml (last visited Apr. 17, 2018) 
(indicating there are risks to the embryo in performing PGD) (on file with the 
Washington & Lee Journal of Civil Rights & Social Justice). 
 40. See Bust a Myth about PGD/PGS, FERTILITY AUTHORITY, 
http://www.fertilityauthority.com/articles/bust-myth-about-pgd-pgs (last visited 
Apr. 17, 2018) (indicating that not everyone should use PGD as it contains 
dangers for the embryo) (on file with the Washington & Lee Journal of Civil 
Rights & Social Justice). 
 41. See id. (listing the most common indications for PGD’s use are 
pregnancies in women thirty-nine and older, severe male factor infertility, two or 
more past miscarriages, and past IVF failures). 
 42. See Merle Spriggs, Is Conceiving a Child to Benefit Another Against the 
Interests of the New Child?, 31 J. MED. ETHICS 341, 341–42 (2005) (explaining 
that PGD can lower the odds that the savior sibling suffers from the same disease 
as the afflicted child). 
 43. See id. (stating that PGD can be used to tissue match the savior sibling 
with the afflicted child). 
 44. See HLA Matching, supra note 9 (noting that siblings only have a 25% 
chance of being a tissue match for each other). 
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immune system rejects the transplantation.45 It is also possible for 
the donated biological material to “reject” the host into whom it 
has been transplanted, causing a serious reaction called graft vs. 
host disease.46 Thus, PGD is required to ensure not only that the 
new child will be free from the disease, but will also be a tissue 
match with the sick child. 
Of course, the concept of savior siblings does not necessarily 
require the use of in vitro fertilization, as a couple could conceive 
naturally.47 Such parents would have to hope that they bear a new 
child who is not afflicted by the condition of their sibling, and hope 
that the new child will be a tissue match with the existing child.48 
In these circumstances, conceiving naturally carries a significant 
risk, that either the baby will be born into a life of suffering and 
pain, or that complications could arise during pregnancy, which 
could threaten the life or well-being of the mother.49 The concept of 
savior siblings need not be restricted to siblings. Indeed, a child 
could be conceived to help cure a sick parent, relative, or other 
member of the family, a concept that will be discussed further 
below.50 Typically, the use of in vitro fertilization and PGD is 
necessary for the creation of savior siblings due to the need to 
match donor tissue matching with the existing sick child.51  
                                                                                                     
 45. See Transfusion Reaction—Hemolytic, U.S. NAT’L LIB. MEDICINE, https:// 
medlineplus.gov/ency/article/001303.htm (last visited Apr. 17, 2018) (describing 
how non-matching biological donations cause the host to reject the transfusion) 
(on file with the Washington & Lee Journal of Civil Rights & Social Justice). 
 46. See Graft vs Host Disease: An Overview in Bone Marrow Transplant, 
CLEV. CLINIC, https://my.clevelandclinic.org/health/diseases/10255-graft-vs-host-
disease-an-overview-in-bone-marrow-transplant (last updated Apr. 17, 2014) 
(explaining that in Graft vs. Host Disease “the donated bone marrow or peripheral 
blood stem cells view the recipient’s body as foreign, and the donated cells/bone 
marrow attack the body”) (on file with the Washington & Lee Journal of Civil 
Rights & Social Justice). 
 47. Janelle Mills, Understanding the Position of the Savior Sibling: Can We 
Save Lives and Protect Savior Siblings, WAKE FOREST U. GRADUATE SCH. ARTS & 
SCI., at ix (Dec. 2013), https://wakespace.lib.wfu.edu/bitstream/handle/10339/391 
13/Mills_wfu_0248M_10493.pdf (on file with the Washington & Lee Journal of 
Civil Rights & Social Justice). 
 48. See id. at 2 (discussing the risks associated with having a child naturally, 
specifically, that the fetus may have the same illness as the sick child).  
 49. Id. 
 50. See infra C. Slippery Slope(analyzing “slippery slope” arguments and 
ways in which the “savior siblings” process could be abused). 
 51. See generally S. Sheldon & S. Wilkinson, Should Selecting Savior 
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A. When are savior siblings considered? 
The decision to create a savior sibling is by no means common. 
This section will discuss conditions for which savior siblings might 
be a plausible treatment, and point out ethical implications of 
these conditions. Consideration of savior siblings is only 
biologically appropriate under a specific set of circumstances.52 
First of all, the disease affecting the sick individual must have 
some genetic component or be readily identifiable with genetic 
testing.53 This is important because, as mentioned above, it is 
essential that the savior does not suffer the same condition as the 
sick child.54 While pre-implantation diagnosis is an evolving and 
advancing field, we currently only have the ability to perform 
genetic testing on an embryo for a select list of genetic conditions.55 
These conditions are the only ones that we can currently ensure, 
through screening, will not be present in the savior embryo, prior 
to implantation.56  
Secondly, savior siblings should only be considered when a 
child is suffering from a disease that is serious enough to 
necessitate intervention, but which can only be treated through 
the use of transplantation.57 Most savior siblings have been 
employed to ameliorate life-threatening conditions, both genetic 
                                                                                                     
Siblings be Banned?, 30 J. MED. ETHICS 533, 537 (2004) (arguing that “the 
selection of saviour siblings should be permitted, especially given that prohibiting 
it would result in the preventable deaths of a number of existing children”).   
 52. Bruce Dickens, Preimplantation Genetic Diagnosis and ‘Savior Siblings’, 
88 INT’L J. GYNECOLOGY & OBSTETRICS, 91, 92–94 (2005). 
 53. See id. (outlining the elements of pre-implantation genetic diagnosis); see 
also Dayal et al., supra note 36 (explaining the science behind pre-implantation 
genetic diagnosis).  
 54. See id. (explaining that only unaffected embryos are transplanted as to 
avoid replicating the genetic disorder).  
 55. See PGD Testable Diseases, THE FERTILITY INSTITUTE, http://www. 
fertility-docs.com/programs-and-services/pgd-screening/genetic-diseases-tested-
for-with-pgd.php (last visited Apr. 17, 2018) (advertising the Fertility Institute’s 
ability to screen for over 400 hereditary diseases during the embryo stage) (on file 
with Washington & Lee Journal of Civil Rights & Social Justice).  
 56. Id.  
 57. See Dickens, supra note 52, at 93–96 (outlining the policy concerns 
considered by a handful of countries in the debate over the use of pre-implantation 
genetic diagnosis).  
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and otherwise.58 This Article does not categorically suggest that 
savior siblings should not be used to provide transplantations for 
elective procedures, or procedures that will simply improve quality 
of life. However, if there is no life-threatening condition being 
suffered, it is much more difficult to ethically justify the creation 
of a savior child.59 While most of my analysis focuses on savior 
siblings used to treat debilitating and generally fatal conditions 
that are not curable through other means, the potential for abuse 
in this regard will be discussed later, as it provides support for 
seeking some form of regulation of this procedure.  
Savior siblings provide biological material, so any disease that 
could be treated through a transplant, could theoretically be 
treated by means of a savior sibling.60 While transplantation 
immediately conjures images of organ harvesting, it can actually 
refer to a broad range of biological material transplantation, with 
organs perhaps being the rarest material harvested.61 Up to this 
point, savior siblings have been utilized to treat conditions that can 
be cured through the transplantation of hematopoietic stem cells, 
derived from bone marrow, umbilical cord blood, or peripheral 
blood.62 Nonetheless, this technology and practice could easily be 
utilized to harvest a more significant donation, such as a kidney or 
another organ, which would have troubling implications.63 
                                                                                                     
 58. See id. (describing several high-profile uses of pre-implantation genetic 
diagnosis by families due to the serious and life-threatening nature of disease 
experienced by a child). 
 59. See id. at 95 (addressing many of the ethical issues which challenge the 
use of pre-implantation genetic diagnosis and other reproductive technologies). 
 60. Id. 
 61. See Todd Pesavento, Facing Organ Donor Shortage, Patients Forced to 
Get Creative, LIVESCIENCE.COM (Oct. 20, 2015), http://www.livescience.com/ 
52526-rarity-of- organ-donations-forcing-patients-to-get-creative.html (reporting 
on the unconventional ways patients have attempted to circumvent the shortage 
of organ donations available for transplantation) (on file with Washington & Lee 
Journal of Civil Rights & Social Justice). 
 62. See Susan M. Wolf et al., Using Preimplantation Genetic Diagnosis to 
Create a Stem Cell Donor: Issues, Guidelines & Limits, 31 J. L. MED. & ETHICS 
327, 329–35 (2003) (outlining the ways in which stem cells from savior siblings 
have provided important biological material). 
 63. See id. at 334 (recommending a framework that requires judicial review 
of bone marrow and solid organ transplant “to determine whether the harvest is 
in the best interest of the donor child”). 
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Hematopoietic stem cell transplant can be used to combat an 
evolving list of diseases, but is most often associated with fighting 
cancers of the blood and bone marrow.64 These range from 
commonly known conditions like leukemia, Hodgkin’s and Non- 
Hodgkin’s Lymphoma, and solid tumor cancers, to certain 
hematologic diseases (non-cancerous blood diseases) and metabolic 
conditions.65  
Thirdly, consideration of a savior sibling should only occur 
when there is no viable tissue donor that can be found for the sick 
child.66 While “transplantation from an HLA identical sibling is 
associated with a much higher success rate than a transplant from 
alternative donors,”67 an existing tissue match renders the creation 
of a savior sibling unnecessary.68 The presence of an existing donor 
eliminates the ethical quandaries raised by the creation of savior 
siblings, discussed below. Furthermore, an older, more developed 
person has more biological material to donate, especially when 
compared to a very young child who may not be fully developed in 
key aspects.69  
Finally, the condition that requires transplantation must not 
be immediately life threatening, as it can take several years for a 
savior sibling to be able to provide the necessary biological 
                                                                                                     
 64. See Ajay Perumbeti, Hematopoietic Stem Cell Transplantation, 
MEDSCAPE (Nov. 13, 2017), http://emedicine.medscape.com/article/208954-
overview (discussing the biological mechanisms of hematopoietic stem cell 
transplantation (HSCT) and medical indications for HSCT treatment) (on file 
with Washington & Lee Journal of Civil Rights & Social Justice). 
 65. Id. 
 66. See G.N. Samuel et al., Establishing the Role of Pre-Implantation Genetic 
Diagnosis with Human Leucocyte Antigen Typing: What Place do “Saviour 
Siblings” have in Paediatric Transplantation?, 94 ARCH. DIS. CHILDHOOD 317, 
318–20 (2009) (“Discussions regarding this technology may be appropriate where 
no suitable related donor is available and transplantation is only likely to be 
entertained with a matched sibling donor.”). 
 67. See Katrien Devolder, Preimplantation HLA Typing: Having Children to 
Save our Loved Ones, 31 J. MED. ETHICS 582, 582 (2005) (addressing critics of pre-
implantation tissue typing as a method of ensuring that potential donor children 
are a tissue match). 
 68. See id. at 583–88 (“The underlying reasoning is that when PGD is used 
to test for genetic diseases that testing is done in the best interests of the embryo 
or the person it will become, whereas when PGD is used solely for tissue typing, 
the only benefit is for the existing sick child.”). 
69. See generally Samuel et al., supra note 66.  
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material to the sick child.70 The amount of time before a savior 
sibling can provide material to treat a child varies depending on 
exactly what material is needed.71 In the case where the umbilical 
cord would provide sufficient stem cells, the cure can be harvested 
immediately after birth, with no further requirement from the 
savior sibling.72 In cases where bone marrow or some other 
material are needed however, it can be several years before a 
savior sibling can function as a viable donor.73  
While potential for abuse exists, a strict analysis of conditions 
where consideration of savior siblings would be appropriate is of 
utmost importance. These conditions combine to make the use of 
savior siblings, objectively quite rare. 
III. Ethics 
The ethical issues raised by savior siblings vary and depend 
on the type of transplantation required.74 Many believe that the 
ethical questions exist on a spectrum, reflecting the invasiveness 
of the tissue being transplanted.75 This spectrum views non-
invasive transplantation, such as the use of umbilical cord blood, 
as less objectionable than a more extensive procedure, such as the 
donation of bone marrow, and these procedures similarly being less 
objectionable than a permanent donation such as a kidney or 
another vital organ.76 No matter the degree of invasiveness, there 
are a few key arguments advanced in nearly any framework 
dealing with savior siblings.  
                                                                                                     
 70. See id. at 319 (explaining that IVF and PGD for HLA typing with the 
goal of one day performing a biological material donation is only appropriate in 
non-urgent transplantation cases). 
 71. Id. at 319. 
 72. Id. at 319. 
 73. See generally Devolder, supra note 67, at 585 (noting how age is a factor 
in bone marrow donations). 
 74. See id. at 584 (discussing the ethical issues raised by various 
transplantation procedures). 
 75. See id. (discussing the range of acceptability of donor transplantations 
from the “widely accepted” umbilical cord blood harvest to the “not accepted” vital 
organ harvest). 
 76. Id. 
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A. Concerns about the New Child 
Many of the ethical arguments against the use of savior 
siblings focus on the status and welfare of the newly conceived 
child.77 One specific concern relates to commodification of the 
savior sibling. In a procedure such as tissue donation, it is difficult 
to argue that the savior sibling is not, in some way, being used as 
a means (providing a cure) to an end (curing an existing sick 
child).78 Many philosophers, particularly Kantians,79 will object on 
this basis. One could respond that while the savior sibling is being 
used a means, it is not merely a means to an end. Indeed, a savior 
sibling serves a much more complicated role: that of a savior, a 
family member, and an individual person. Of course, worries of 
commodification must be addressed, as without the savior sibling’s 
role of providing biological material that allows for the curing of a 
sick child, it is unlikely that this specific individual would exist. 
This is because a great deal of effort and technology must be 
invested to ensure that the new child meets the specific conditions 
necessary to serve as a donor (namely that they are free from the 
disease, and are an HLA match with the existing sibling). 
The commodification argument plays into the larger 
contention that being used as a savior sibling damages the welfare 
of the new child.80 Some argue that the new child may feel like they 
only exist to serve their sick sibling, as a simple cog in the family 
machine that decided to create them.81 This could lead to feelings 
                                                                                                     
 77. See Sally Sheldon & Stephen Wilkinson, ‘Saviour Siblings’: Hashmi and 
Whitaker. An Unjustifiable and Misguided Distinction, PROCHOICEFORUM (2005), 
http://www.prochoiceforum.org.uk/irl_rep_tech_2.asp#top (outlining the ethical 
controversies surrounding savior siblings as presented in two cases decided by 
the Human Fertilisation and Embryology Authority) (on file with author). 
 78. See generally Jose Silber, Is it Ethical to Have a Child to Save a Child?, 
13 AAP GRAND ROUNDS 30, 30 (2005). 
 79. Id. 
 80. See Mariana Do Carmo, Child Autonomy and the Rights to One’s Own 
Body: PGD and Parental Decision Making, THEBIOETHICSPROJECT (Feb. 13, 
2013), http://www.thebioethicsproject.org/essays/child-autonomy-and-the-rights-
to-ones-own-body-pgd-and-parental-decision-making/ (discussing ethical 
considerations of savior siblings as related to the wellbeing of the child) (on file 
with author).  
 81. See, e.g., Allane Madanamoothoo, Saviour-Sibling and the Psychological, 
Ethical and Judicial Issues that It Creates: Should English and French 
Legislators Close the Pandora’s Box?, 18 EUR. J. HEALTH L. 293, 301 (2011) 
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of depression and a lack of self-worth or malaise, as the child may 
not feel special in their own right, but rather that they are forever 
tied to their sibling.82 It has been argued that serving as a savior 
sibling solely benefits the parents and sick child, as the savior may 
be subjected to invasive, and potentially painful, procedures that 
provide no direct biological benefit to them as an individual.83 
Indeed, while many of these procedures are simple, some of them, 
such as bone marrow transplant, can be extremely painful.84 
These concerns become even starker when parents wish to 
undertake a more significant transplantation from a savior 
sibling.85 While utilizing the umbilical cord that is otherwise 
discarded may be morally acceptable, there is greater risk if 
saviors were to donate biological materials such as organs or other 
tissues.86 Harvesting an organ can result in a lifetime of 
differentiated care and health problems, including the possibility 
of a shortened life span.87 With no obvious benefit to the new child, 
                                                                                                     
(“[T]hey may feel of having been conceived for the sole purpose of caring for their 
elder brother or sister.”). 
 82. See Sally Sheldon & Stephen Wilkinson, Should Selecting Saviour 
Siblings Be Banned?, 30 J. MED. ETHICS 533, 534 (2004); see also Savior Siblings: 
At What Moral Cost?, ZENIT (Mar. 23, 2011), http://zenit.org/articles/savior-
siblings-at-what-moral-cost/ (concluding that selecting savior siblings should not 
be banned) (on file with the Washington & Lee Journal of Civil Rights & Social 
Justice). 
 83. See generally LORI KNOWLES & GREGORY E. KAEBNICK, REPROGENETICS: 
LAW, POLICY, AND ETHICAL ISSUES (2007) (bringing together bioethicists from the 
United States, Canada, and the United Kingdom to examine the ethical and policy 
questions created by new genetic technologies). 
 84. See, e.g., Martha Bebinger, From Cheek Swab To Operating Room: 
What’s It Really Like To Donate Bone Marrow?, WBUR (May 13, 2014), 
http://commonhealth.wbur.org/2014/05/what-its-like-to-donate-bone-marrow 
(highlighting David Cavell’s journey of donating bone marrow) (on file with the 
Washington & Lee Journal of Civil Rights & Social Justice). 
 85. See, e.g., Risks Involved in Living Donation, KIDNEYLINK, http://www. 
kidneylink.org/RisksInvolvedinLivingDonation.aspx (last visited Apr. 17, 2018) 
(discussing risks associated with kidney donation, including: high blood pressure, 
the kidney not functioning properly after recipient receives the transplant, 
unforeseen problems the donor may experience, body image problems from the 
surgical scars, and feelings of anger or anxiety) (on file with the Washington & 
Lee Journal of Civil Rights & Social Justice). 
 86. See id. (explaining the dangers that savior siblings face in donating 
certain organs). 
 87. See id. (emphasizing the long-term risks associated with savior siblings 
donating organs). 
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there seems to be a clear difference if a savior sibling is created for 
a donation more invasive than bone marrow, as such a process 
disregards the welfare of the savior, in favor of the health of the 
sick child and the happiness of the family unit.  
Invasive donation is particularly problematic, given that the 
savior sibling is not afforded the same level of autonomy that a 
normal individual is given when deciding to consent to a 
transplant of biological material.88 It is important to note that 
autonomy is necessary for an individual to give consent to a 
procedure.89 Autonomy can be violated through coercion or 
pressure, which removes an individual’s ability to give genuine 
consent, or by not providing an individual with the option of 
consenting.90  
Savior siblings present a unique situation with the issues of 
consent and autonomy for several reasons. Firstly, as the child was 
created specifically to serve as a donor, the individual does not 
have the chance to “agree” to serve as a savior sibling.91 This means 
that the only wishes that get expressed, when deciding whether or 
not to create a savior sibling, are those of the parents.92 Some argue 
that this fundamentally undermines the ability of that individual 
to ever give meaningful consent, as they were created for the 
purpose of serving as a transplant, whether they want to or not.93 
                                                                                                     
 88. See Kimberly Strong et al., Savior Siblings, Parenting and the Moral 
Valorization of Children, 28 BIOETHICS J. 187, 188–90 (2014) (testing the ethical 
objection to savior siblings and concluding that the ethical objections rely heavily 
on speculative arguments and inappropriately scrutinize parental motives). 
 89. See K. Satyanarayana Rao, Informed Consent: An Ethical Obligation or 
Legal Compulsion?, 1 J. CUTANEOUS AESTHETIC SURGERY 33, 33–35 (2008) 
(claiming that informed consent is an ethical and legal obligation). 
 90. See id. (asserting that no one has the right to coerce the patient to act in 
any way, not even a doctor). 
 91. See Kiley Bonk, Minors as Living Organ Donors: Protecting Minors from 
Martyrdom, 28 CHILD. LEGAL RTS. J. 45, 45 (2008) (considering the legal 
safeguards in place with regard to organ donation by minors and discussing the 
possible side effects). 
 92. See id. (discussing the inability of savior siblings to consent to their role 
in the savior sibling process). 
 93. See Steven Ertelt, Rescue Me: The Moral and Ethical Problems of 
Creating Savior Siblings, LIFENEWS (Aug. 8, 2008), http://www.lifenews.com/2008 
/08/08/bio-2540/ (discussing ethical issues with savior siblings and consent) (on 
file with Washington and Lee Journal of Civil Rights & Social Justice). 
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Some scholars question whether consent from the savior 
sibling is even factored in to the decision to harvest biological 
material in the first place.94 In many cases, the child may be too 
young to have the capacity to offer their own consent.95 There are 
several levels of concern regarding consent that relate to the 
invasiveness of the proposed procedure.96 To wit, it is probably not 
very important that we obtain a newborn’s “consent” to use their 
umbilical cord, which is arguably considered a part of the mother 
anyway, and is traditionally discarded.97 But if the procedure 
involves significant pain, or a potentially life-long alteration of the 
savior sibling’s quality of life, one would agree that then it becomes 
more important to have the consent of the individual.  
Scholars question whether savior siblings will face undue 
pressure from their family unit, meaning that even if they chose to 
serve as donors, this may not be a genuinely autonomous choice.98 
Undue pressure can remove a normal individual’s ability to 
consent to a procedure, to say nothing of a young child.99 Even with 
supportive parents, children may feel compelled to fulfill their 
family’s wishes, and feel a sense of responsibility for their sibling’s 
life, which only they are able to “save.”100  
                                                                                                     
 94. See generally KNOWLES & KAEBNICK, supra note 83, at 187–89 
(considering the benefits and risks of combining reproductive technologies).  
 95. See Lawrence Schlam & Joseph Wood, Informed Consent to the Medical 
Treatment of Minors: Law and Practice, 10 HEALTH MATRIX: J. LAW-MED. 141, 142 
(2000) (analyzing the competence of minors and discussing the requirement of 
informed consent when treating minors). 
 96. See id. (discussing the different ethical questions involved in medical 
decisions for minors). 
97. See Donating Umbilical Cord Blood to a Public Bank, HEALTH 
RESOURCES & SERVS. ADMIN., https://bloodcell.transplant.hrsa.gov/cord/options/d 
onating/index.html (last visited Apr. 17, 2018) (explaining the process of 
donating umbilical cord blood and how the umbilical cord is typically discarded) 
(on file with the Washington & Lee Journal of Civil Rights & Social Justice). 
 98. See, e.g., Strong et al., supra note 88, at 187–89 (discussing the moral 
significance and pressures from the parents of a savior sibling). 
 99. See, e.g., Cameron Stewart & Andrew Lynch, Undue Influence, Consent 
and Medical Treatment, 96 J. ROYAL SOC’Y MED. 598, 599 (2003) (explaining the 
influence of the doctor-patient relationship when consenting to medical 
treatment). 
 100. See id. (providing an example of a child who felt responsible for the life 
of their sibling). 
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Superimposed on the issue of consent specific to the savior 
sibling situation is the more general issue of informed consent in 
children. Young children generally lack a true understanding of 
medical procedures and what they entail.101 A full discussion of 
this is beyond the scope of this Article, but the issue clearly imparts 
an ethical consideration. 
While some highlight the magnitude of such ethical pitfalls,102 
other scholars argue that creating savior siblings may not lead to 
the negative scenarios imagined.103 These scholars point out that, 
when considering ethical objections to the creation of a savior 
sibling, we must do our best to try to assess what effect being a 
savior sibling has on a child to determine whether the fears and 
concerns that people raise are well founded, or alarmist.104 
B. Available Data 
While the arguments raised above seem persuasive, there is 
currently little direct evidence to back up claims that being a savior 
sibling is damaging to the welfare, psychological or emotional 
health of the savior sibling.105 It is essential to note, that this 
evidence is lacking, primarily because of the novelty of the 
procedure, and the absence of serious, long-term investigation.106 
                                                                                                     
 101. See id. at 600–04 (discussing the influence of family members on a child’s 
decision making abilities). 
 102. See, e.g., Wesley J. Smith, “Savior Siblings” Start Us Down Harrowing 
Ethical Path, CENTER FOR BIOETHICS & CULTURE (Mar. 3, 2011), http://www.cbc-
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 103. See, e.g., Guido Pennings, Saviour Siblings: Using Preimplantation 
Genetic Diagnosis for Tissue Typing, 1266 INT’L CONG. SERIES 311, 312–17 (2004) 
(weighing ethical concerns regarding savior siblings). 
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 105. See Sheldon & Wilkinson, supra note 51, at 534 (finding that arguments 
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 106. See id. at 536 (“[F]ull consideration of the issue of psychological harm 
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something that we can do here).”). 
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Many have criticized the available quality of life studies as 
relying too much on self-reporting,107 and for lacking objective 
indices about appropriate quality of life criteria.108 Despite these 
flaws, interviews and anecdotal data suggest that many savior 
siblings have relatively normal, uncomplicated lives, free from 
philosophical concerns about their creation or place in the 
universe.109 I argue that parents who undergo the extensive 
process needed to have a savior sibling are unlikely to simply 
disregard or treat the savior child poorly, just because their 
function as a donor is over. Indeed, given the extensive time, 
money, effort, and difficulty, involved in having a savior sibling, 
the process is unlikely to be undertaken by parents who are not 
concerned with caring for their children. It is just as likely that 
parents might show increased care for the savior sibling, as the 
savior has played an integral role in preserving the family unit.  
Further, although there is some argument that psychological 
harm could occur if a child finds out that he or she was wanted not 
for himself or herself, but rather for the ulterior purpose of 
assisting a sibling to live, anecdotal interview data report high 
level of satisfaction for the savior sibling.110 This may be due to the 
fact that it seems just as likely that that child will feel pride and 
contentment in the knowledge that he or she is responsible for 
saving the life of a sibling.111 These feelings of pride seem to extend 
to the knowledge that the savior was created for a specific purpose. 
Interviews with savior siblings also suggest that worries about 
commodification, and reason for birth, do not seem to produce 
                                                                                                     
 107. See Self-Report Measures: Notoriously Unreliable, INTROPSYCH, http:// 
www.intropsych.com/ch01_psychology_and_science/self-report_measures.html 
(last visited Apr. 17, 2018) (noting the unreliability of studies which collect data 
via self-reporting) (on file with the Washington & Lee Journal of Civil Rights & 
Social Justice). 
 108. See Pedro Conceição & Romina Bandura, Measuring Subjective 
Wellbeing: A Summary Review of the Literature 2–7 (United Nations Dev. 
Programme Dev., Working Paper No. 2, 2008) (finding flaws in the traditional 
method of studying quality of life). 
 109. Telephone Interviews by Zachary Shapiro with various hospitals and 
fertility clinics in the United Kingdom (2011–2012) (notes on file with author). 
 110. See Bonk, supra note 91, at 45–49 (considering the potential 
psychological benefits of living organ donation).  
 111. See generally Grewal et al., supra note 14 (providing an example of a case 
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serious negative mental and emotional consequences for the savior 
sibling.112 Many siblings report not only high levels of personal 
pride, and satisfaction, but also a unique feeling of connection with 
their sick, older sibling.113  
Despite these sanguine reports, there is reason to have 
concerns regarding the self-reported experience of savior 
siblings.114 Self-reported happiness and quality of life studies have 
a long history of subjectivity, and unreliability.115 Given the 
novelty of this procedure, there is simply so little primary evidence 
that we cannot conclude whether the initial evidence is 
generalizable, or whether it is an outlier.116 Indeed, the absence of 
evidence showing harm might be meaningless if the data are not 
robust.117 Furthermore, research design, implicit bias, and 
researcher agenda can have a tremendous impact on social science 
research, as can the way in which a question is phrased or the 
manner the interview is conducted in.118 These concerns ring 
especially true when interviewing children.119  
Given the limited amount of data on the savior sibling 
experience, it may be helpful to turn to studies of similarly situated 
individuals.120 One such study, performed by MacLeod, Whitsett, 
Mash, and Pelletier, examined a small number of children who 
donated stem cells to their sibling via a painful, but not dangerous, 
                                                                                                     
 112. See MacLeod et al., infra note 120 (describing positive mental and 
emotional results derived by a savior sibling). 
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 114. See generally David Lipinski & Rosemary Nelson, The Reactivity and 
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bone marrow biopsy.121 The study contrasted the effects on the 
children involved depending on whether the transplant was 
successful or unsuccessful.122 
 
There is good reason to believe that these data are meaningful 
for the savior sibling situation, as the process of donation is the 
same for savior siblings and children who donate biological 
material but who were not specifically conceived as savior siblings. 
The study found that children who had donated stem cells in a 
successful transplant procedure had a generally positive view of 
the experience.123 The children reported that the process had many 
positive effects on their lives.124 Crucially, investigators noted that 
negative feelings of anger, guilt, and blame were present amongst 
donors who participated in unsuccessful transplants, or if the 
donor child was uninformed about potential medical complications 
or did not receive adequate support afterwards.125 This highlights 
that donation can be ethically conducted, but should involve honest 
discussion with the donor. Furthermore, it highlights that savior 
siblings, like any donor children, will need to have a well-
established support network in place at home.126 
In conclusion, lack of evidence of harm to savior siblings does 
not mean that harm is not occurring, and further study is essential 
before we can draw meaningful conclusions. Study design will be 
key in generating effective, longitudinal data. It will be necessary 
to assure that the right parties are gathering the evidence, and 
that appropriate methodologies are employed. Of course, 
researchers must be careful to ensure that any large scale 
collection of data is conducted ethically.127 Work should be done to 
                                                                                                     
 121. Id. at 225. 
 122. Id. 
 123. See id. at 227 (“Nearly all sibling donors who participated in a successful 
HSCT believed their participation had a predominantly positive impact on many 
life domains, including relationships, view of world, feelings about self and 
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 127. See generally Ben Berkman et al., The Ethics of Large Scale Genomic 
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de-identify any sensitive information, along with other appropriate 
steps to ensure privacy and protection of data.128 The absence of 
such data should lead us to be skeptical of claims which argue that 
evidence should push us one way or the other, in this highly-
charged field. 
C. Slippery Slope 
While current uses of savior siblings are limited, a number of 
potential troubling ethical issues have been mentioned.129 These 
ethical issues may seem benign when applied to an individual case 
at this point, but, when taken in aggregate, could pave the road for 
troubling practices in the future.130 Indeed, proponents of “slippery 
slope” arguments are concerned about discussions regarding savior 
siblings and the number of ways in which this process could be 
abused.131 
The general question is whether any use of savior siblings 
paves the way for the potential utilization of savior children for 
purposes that society does not find acceptable. This could occur in 
two distinct ways. The first concern is that, although savior 
siblings are currently used for less invasive donations, such a 
process opens up the potential to one day harvest significant 
biological material, such as organs, limbs, or tissues, which could 
seriously harm the savior sibling, or lead to a compromised quality 
of life.132 As discussed above, the ethics surrounding savior siblings 
significantly change if the biological material being harvested will 
result in a lifetime of differentiated function or care for the 
                                                                                                     
Research, ETHICAL REASONING IN BIG DATA: AN EXPLORATORY ANALYSIS (2015) 
(discussing the ethical considerations associated with big data in “biomedical 
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 131. See John A. Robertson et al., Conception to Obtain Hematopoietic Stem 
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savior.133 Indeed, donation of any organ, from a kidney, to an eye, 
to a lung, would cause a form of permanent harm to the savior 
child,134 and might be wholly unacceptable to our society. While 
savior siblings are currently primarily used for umbilical cord 
blood and bone marrow donations, we must keep in mind this 
potential for abuse, so we can safeguard against more intrusive 
donations.135  
The other slippery slope argument questions whether the 
recipients of the donations will one day change, from sick siblings 
today to perhaps a parent, elderly family member, or even someone 
outside the family unit.136 The prospect of parents using this 
mechanism to provide themselves, or other relatives or friends, 
with biological material, is rightfully troubling, even to the most 
ardent supporters of the savior sibling model.137 
Such scenarios raise significant ethical red flags, as this 
situation would involve harming a new child, solely for the benefit 
of another individual, who lacks the direct connection with the 
savior that a sick brother or sister would share. The motivation 
behind the decision would also be twisted, as this could present a 
scenario where parents decide to have a savior child to save their 
own life, or the life of others without an immediate family 
connection, complicating our notions of parental decision-making 
and autonomy.138  
Other objections focus on the notion that IVF and PGD could 
be used to usher in a new age of eugenics, as advances allow 
parents to select certain traits and favor select characteristics over 
                                                                                                     
 133. See Devolder, supra note 67, at 584–85 (discussing how umbilical cord 
blood harvest and bone marrow donations are accepted procedures but that 
harvesting vital organs is not). 
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others.139 While there is limited evidence at this juncture, given 
the scientific community’s history of problematic utilization,140 
such objections should not be dismissed lightly.141 Recognition of 
the issues raised in these “slippery slope” arguments should not 
lead to a ban on the procedure. They instead argue for the 
importance of creating a robust regulatory framework to guide, 
and monitor, decision making in this area.  
D. Regulation and Decision Making Regarding Savior Siblings 
Given the ethical pitfalls discussed above, and the genuine 
potential for abuse, the question of who gets to make the decision 
about whether to have a savior sibling is complicated. Such a 
debate pits traditional arguments of parental rights and autonomy 
against arguments concerning the welfare of the savior sibling.142 
Ultimately, this leads to the question of whether there is a role for 
some form of governmental regulation.  
There is a long-standing tradition in the Western World of 
allowing parents be the ultimate arbiter of medical and family 
planning decisions for their individual family unit.143 These ideals 
clash with arguments about the welfare of the child, if there is a 
perception that the family is either disregarding a child in a 
                                                                                                     
 139. See generally Armand Marie Leroi, The Future of Neo-Eugenics. Now 
That Many People Approve the Elimination of Certain Genetically Defective 
Fetuses, Is Society Closer to Screening All Fetuses for All Known Mutations?, 7 
EMBO REP. 1184, 1184–85 (2006) (arguing that there might be less resistance in 
the future to more sophisticated methods of eugenic selection). 
 140. See generally Michael J. Malinowski, Choosing the Genetic Makeup of 
Children: Our Eugenics Past-Present, and Future?, 36 CONN. L. REV. 125, 134–49 
(2003) (discussing the origins of eugenics, how the Nazi state used it as a 
rationalization for selective breeding, sterilization, and human experimentation, 
and the history of the development of eugenics in the United States). 
 141. See Hilary White, Eugenics Threat Growing in IVF Industry: British 
fertility expert, LIFESITENEWS (Apr. 8, 2013), https://www.lifesitenews.com/news/ 
eugenics-threat-growing-in-ivf-industry-british-fertility-expert (quoting Lord 
Robert Winston as saying that “[w]e may find that people well want to modify 
their children, enhance their intelligence, their strength and their beauty and all 
the other so-called desirable traits”) (on file with the Washington & Lee Journal 
of Civil Rights & Social Justice). 
 142. See Do Carmo, supra note 80 (discussing the tension between a potential 
savior child’s rights and parental rights). 
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harmful way, or making a decision that flies in the face of 
traditional notions of morality.144 Both of these fears are present 
when discussing savior siblings, as not only do many believe that 
the procedure disregards (and is perhaps, contrary to) the welfare 
of the savior sibling, but also the process seems to eschew 
traditional conceptions of family morality and planning.145 Indeed, 
rarely are the reasons behind having a second child as transparent 
and tangible as they are in the case of savior siblings. 
Regarding objections concerning the motivation of parents 
who decide to have a savior sibling, there are a myriad of motives 
commonly accepted as acceptable for family planning.146 While 
they may not be as transparent as the decision to have a savior 
sibling, they often come with far less genuine good as a result. 
Parents have children to create an heir, continue a legacy, serve as 
a playmate for a child, strengthen a relationship (or even save a 
marriage), or to fulfill another, inherently selfish, desire of the 
parents.147 While a variety of these decisions may be frowned upon, 
there is no suggestion that parenting should be restricted only to 
those who have a “good reason” to conceive.148  
Contrasting these cases with the decision to create a savior 
sibling, there is actually a great deal of genuine good that comes in 
the latter case, as an existing child is able to continue living, and 
the family unit does not have to suffer the devastating 
consequences of losing a child.149 While it is newer, creating a 
savior sibling may not be a “worse” reason for having a child then 
our traditionally selfish motives.150 Furthermore, questioning 
birth motives could open up Pandora’s Box concerning whether 
society, or governments, should have a role in deciding which 
reasons are acceptable for birth, and which are not.  
The case of savior siblings is one in which the upmost caution 
is warranted, making it difficult to argue that there should be no 
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 146. See Devolder, supra note 67, at 583–84 (listing the various motivations 
for having a child). 
 147. Id. 
 148. Id. 
 149. See MacLeod et al., supra note 120, at 227 (“[S]aving my brother’s life 
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 150. See generally Devloder, supra note 67, at 584–85. 
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regulation or oversight of any sort.151 While many might agree that 
there are certain, limited circumstances where creating a savior 
sibling is ethically defensible, others point out the genuine 
potential for abuse in a myriad of avenues.152 As mentioned above, 
the ethical calculus for savior siblings changes, depending on 
factors such as what disease is being treated, what donation is 
being sought, how many procedures the savior will be subjected to, 
who is being saved, and other factors.153 The answer to these 
questions might change the ethical acceptability of creating a 
savior sibling. Leaving this decision to the sole discretion of the 
parents or a given fertility clinic is problematic. Such a situation 
could allow disparate outcomes for similarly situated individuals, 
to say nothing of the potential for harm and abuse for the savior 
child.  
IV. Regulatory Issues in the United States 
Many of the ethical concerns detailed above play out in the 
larger debate over whether, and to what extent, society should seek 
to regulate the decision-making and issues that arise surrounding 
the creation of savior siblings.154 Examining the status of savior 
siblings in the U.S. reveals that there is little to no governmental 
regulation, nor are there any robust guidelines, standards, or 
licensing procedures steering professional organizations that are 
involved in the creation of savior siblings.155  
                                                                                                     
 151. See Malinowski, supra note 140 (analyzing the history of eugenics and 
discussing its abuses). 
 152. See generally Leroi, supra note 139 (discussing the use of abortion as a 
eugenic practice). 
 153. See generally Devolder, supra note 67. 
 154. See Aaron R. Fahrenkrog, A Comparison of International Regulation of 
Preimplantation Genetic Diagnosis and A Regulatory Suggestion for the United 
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 155. See id. at 768 (“At present, no U.S. jurisdiction has issued legislation or 
guidelines for the regulation of PGD with the exception of New York.”). 
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A. Formal and Informal Regulation 
There is no governmental regulation or specific legal guidance 
on the topic of savior siblings in the U.S.156 Indeed, there are no 
federal regulations in the U.S. that deal explicitly with the use of 
PGD.157 Because of this, uses of PGD, such as the creation of a 
savior sibling, are currently left to the discretion of providers and 
patients.158
  
This lack of regulation avoids governmental interference in 
personal choices related to birth, ultimately enabling the scientific 
community to continue without guidance or oversight. Scholars 
describe this scheme of regulation as “voluntary certification.”159 
While the CDC developed a model certification template program 
for assisted reproduction clinics and laboratories160 in accordance 
with the Fertility Clinic Success Rate and Certification Act of 1992 
(Fertility Act),161 discretion was left to individual states as to 
whether or not they implement the scheme.162 Partially due to this 
flexibility, no state has fully adopted the model program, and 
scholars maintain that the sector has been mostly left to self-
police.163 The guidance does not consider savior children.
 
Indeed, the only governmental action that may be described 
as “regulation” is the ban on federal funding for embryo-related 
research.164 Funding is currently only approved for research 
conducted on cells derived from embryos less than two weeks old, 
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 157. Id. 
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 159. See Malinowski, supra note 140, at 182 (“The United States federal 
regulatory scheme for ART clinics can be summarized as voluntary 
certification.”). 
 160. Implementation of the Fertility Clinic Success Rate and Certification Act 
of 1992-A Model Program for the Certification of Embryo Laboratories, 64 Fed. 
Reg. 39374 (July 21, 1999). 
 161. Fertility Clinic Success Rate and Certification Act of 1992, Pub. L. No. 
102-493, 106 Stat. 3146 (codified at 42 U.S.C. § 201 (1992)).  
 162. Malinowski, supra note 140, at 182. 
 163. See id. (“No state has fully adopted the model program, and the CDC has 
contractually outsourced implementation to SART, meaning that the sector has 
been left to self-police.”). 
 164. See id. at 183–84 (“As a clinical service, ART escapes the FDA’s product 
groupings, and the federal government has long abstained from funding 
embryonic research—thereby further castigating ART to the private sector.”). 
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that are left over from infertility treatment, have been frozen and 
would otherwise be destroyed, or cells derived from frozen embryos 
without destroying the embryos.165 As a result, this means that the 
U.S. government does not play a significant role in the process and 
regulation of IVF, PGD, or decisions regarding savior siblings.166  
While there is no formal government funding, the government 
does have a part to play in the complex cycle of assisted 
reproduction clinics and therapies.167 For instance, the Center for 
Medicare and Medicaid Services (CMS) governs the quality of 
laboratories and laboratory personnel.168 The Food and Drug 
Administration (FDA) generally regulates genetic tests for 
analytical and clinical validity.169 These regulatory bodies do not 
have specific guidance regarding savior siblings.170  
                                                                                                     
 165. See Comm. on Pediatric Research & Comm. on Bioethics, Human 
Embryo Research, 108 AAP NEWS & J. 813, 814, http://pediatrics.aappublications. 
org/content/108/3/813 (last updated Nov. 1, 2001) (“Some individuals who go 
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 166. See Meena Lal, The Role of the Federal Government in Assisted 
Reproductive Technologies, 13 SANTA CLARA HIGH TECH. L. J. 517, 534 (1997) 
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 167. Gutman, infra note 169. See generally Clinical Laboratory Improvement 
Amendments (CLIA), CTR. FOR MEDICARE & MEDICAID SERV. [hereinafter Clinical 
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index.html ?redirect=/Clia (last updated Apr. 5, 2017) (on file with the 
Washington & Lee Journal of Civil Rights & Social Justice). 
 168. See generally Clinical Laboratory, supra note 167. 
 169. See Steven Gutman, The Role of Food and Drug Administration 
Regulation of In Vitro Diagnostic Devices—Application to Genetics Testing, 
CLINICAL CHEMISTRY (May 1999), http://clinchem.aaccjnls.org/content/45/5/746 
(“[G]enetic tests are received and reviewed by the FDA.”) (on file with the 
Washington & Lee Journal of Civil Rights & Social Justice). 
 170. See Michelle J. Bayefsky, Comparative Preimplantation Genetic 
Diagnosis Policy in Europe and the USA and its Implications for Reproductive 
Tourism, 3 REPROD. BIOMEDICINE & SOC’Y ONLINE 41, 41 (2016), http://www. 
rbmsociety.com/article/S2405-6618(17)30004-7/pdf (“[T]he USA has no 
regulations concerning the use of preimplantation genetic diagnosis . . . a 
technique employed . . . for a variety of controversial purposes, including . . . [the] 
selection [of] ‘saviour siblings’ who can serve as tissue donors for sick relatives.”) 
446 24 WASH. & LEE J. CIVIL RTS. & SOC. JUST.419 (2018) 
The lack of formal funding, and governmental regulation, has 
several consequences. First, disallowing funding restricts the 
gathering of data and information regarding the use and 
prevalence of savior siblings.171 The absence of monitoring means 
that any harm that could be happening to savior children may 
currently go unreported, as there is no system in place to follow-up 
on savior families, or chart their long term emotional and physical 
health.172 Furthermore, not having formal regulation results in 
increased authority for clinics performing PGD to make their own 
decisions on the moral and ethical issues discussed above.173 
Because each clinic is able to make their own policies, similarly 
situated individuals in different locations may have vastly 
different options available to them.  
B. Professional Guidelines 
Given the absence of regulatory schema in the U.S., 
professional guidelines, issued by organizations that might be 
expected to consider the status and welfare of savior siblings, can 
reveal expert opinion and professional attitudes. While 
professional guidelines can give a glimpse into informal rules and 
regulations that may influence opinion amongst those who are 
informed of the risks and benefits, review of current guidelines 
reveal a serious lack of consideration regarding savior siblings as 
a whole.174  
                                                                                                     
(on file with Washington & Lee Journal of Civil Rights & Social Justice). 
 171. See R.M.L. Winston, Does Government Regulation Inhibit Embryonic 
Stem Cell Research and Can It Be Effective?, 1 CELL STEM CELL 27, 31–32 (2007) 
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 173. See id. at 32. (“Thirdly, there is anxiety that, with commercial pressure, 
clinical translation of basic science work could be undertaken too soon and 
without adequate safeguards.”). 
 174. Ilan Tur-Kaspa & Roohi Jeelani, Clinical Guidelines for IVF with PGD 
for HLA Matching, 30 REPROD. BIOMEDICE ONLINE 115, 118 (2015), http://www. 
rbmojournal.com/article/S14726483(14)00 582-3/pdf (“[I]n many IVF centers, no 
set guidelines have been established, and most healthcare providers are still 
unaware of such options or how to introduce them to patients.”) (on file with the 
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Groups like the American Society for Reproductive Medicine, 
American Congress of Obstetricians and Gynecologists, and 
American College of Medical Genetics, which create guidelines 
concerning IVF, PGD and other aspects of reproductive medicine 
offer little of relevance.175 Their guidelines do not take strong 
stances on contested ethical topics. Crucially, these organizations 
have yet to take an official stance on savior siblings, and, as a 
result, their guidance documents do not address savior siblings in 
a robust way.  
A non-medical organization that might offer insight is the 
Council on Ethical and Judicial Affairs (CEJA).176 While the CEJA 
discusses organ donation in general, its analysis concerning “un-
emancipated minors and legally incompetent adults” donating 
organs can apply to savior siblings.177 The CEJA determined that 
even though these populations should normally not be considered 
as possible organ donors, minors who are capable of understanding 
may be considered, provided that they share an emotional 
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AM. MED. ASS’N, https://www.ama-assn.org/about-us/about-council-ethical-judic 
ial-affairs-ceja (last visited Apr. 17, 2018) (on file with the Washington & Lee 
Journal of Civil Rights & Social Justice). 
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CEJA Report 6-I-10, at 5 (2010), https://www.ama-assn.org/sites/default/files 
/media-browser/public/aboutama/councils/Council%20Reports/council-on-ethics-
and-judicial-affairs/i10-ceja-nonsimultaneous-altruistic-organ-donation.pdf (on 
file with the Washington & Lee Journal of Civil Rights & Social Justice). 
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connection with the recipient, and have the consent of their 
guardian.178 
In addition to the minor having cognitive capability, the CEJA 
points out that because the parent or guardian providing informed 
consent is emotionally attached to the recipient, precautions, such 
as obtaining a second opinion from an independent ethics 
committee, should be taken.179
 
The CEJA further states that living 
organ donors should consult independent physicians, who are able 
to make decisions reflecting their best interests.180
 
An independent 
doctor is especially important in the case of a savior sibling, in 
order to help ensure that the child is adequately prepared for what 
is to come.181 Such planning will affect how the donor perceives 
their situation, both before and after a procedure. Unfortunately, 
it does not seem like current mechanisms are in place to ensure 
that these criteria are met, before a savior sibling donates 
biological material.  
V. Savior Siblings in the United Kingdom 
The lack of regulation in the U.S. stands in stark contrast to 
regulatory schemes found in other countries, in particular the 
United Kingdom. In the UK, the government regulates PGD by 
requiring a clinic to obtain a license before they can perform the 
procedures that create a savior sibling.182 This is not surprising, 
                                                                                                     
 178. See id. at 5 (“[M]inors with substantial decision making capability who 
agree to serve as donors, with the informed consent of their legal guardians, may 
be considered for donation to recipients with whom they are emotionally 
connected.”). 
 179. See id. (“Since minors’ guardians may be emotionally connected to the 
organ recipient, when an unemancipated minor agrees to donate, it may be 
appropriate to seek advice from another adult trusted by the minor or an 
independent body, such as consultation with an ethics committee, pastoral 
service, or other counseling resource.”). 
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 182. See Bayeski, supra note 170 (“License committees determine whether 
new conditions qualify as appropriate medical uses of PGD after reviewing an 
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given that the UK has a long history of governmental regulation of 
the medical field.183 This results in significant government 
involvement in many aspects of medical technology, and medical 
decision-making. As a result, UK regulators have considered the 
position of savior siblings for some time now.184  
In the UK, PGD is regulated by the Human Fertilization and 
Embryology Act (HFEA).185
 
This Act186 was enacted in 1990, and
 
allows for PGD to be performed in order to test for severe genetic 
diseases and perform tissue type matching for savior siblings 
under strict criteria.187 PGD is allowed for medical purposes 
only.188 To determine whether PGD may be allowed, the 
government provides a list of criteria. These include that:  
(1) the condition of the affected child should be severe or 
life- threatening, of a sufficient seriousness to justify the 
use of PGD; (2) the embryos conceived in the course of this 
treatment should themselves be at risk from the condition 
by which the existing child is affected; (3) all other 
possibilities of treatment and sources of tissue for the 
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 183. See John H. Raach, English Medical Licensing in the Early Seventeenth 
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application in 2001.”) (on file with the Washington & Lee Journal of Civil Rights 
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 186. Human Fertilisation and Embryology Act 1990, c. 37 (Eng.). 
 187. See Gitter, supra note 185, at 989 (“[T]he HFEA also agreed . . . to permit 
PGD with tissue typing.”). 
 188. See Clinical Commissioning Policy: Pre-implantation Genetic Diagnosis, 
NHS COMMISSIONING BOARD (Apr. 2013), https://www.england.nhs.uk/wp-content 
/uploads/2013/04/e01-p-a.pdf (“The following uses of the PGD technology are 
excluded from this policy: Non medical gender selection e.g. for the purpose of 
family balancing. This is illegal in the United Kingdom.”) (on file with the 
Washington & Lee Journal of Civil Rights & Social Justice). 
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affected child should have been explored; (4) the 
techniques should not be available where the intended 
recipient is a parent; (5) the intention should be to take 
only cord blood for the purposes of treatment, and not 
other tissues or organs; (6) appropriate implications 
counseling should be a requirement for couples 
undergoing this type of treatment; (7) families should be 
encouraged to participate in follow-up studies and, as 
with PGD, clinics should provide detailed information 
about treatment cycles and their outcomes.189 
In 2004, fertility regulators in a specialized court ruled that 
the HFEA allows parents to use modern reproductive techniques 
to create a savior sibling.190 The existence of this regulation is 
particularly significant. Indeed, there is tremendous difficulty in 
creating regulation of any topic that is as charged and 
controversial as birth.191 The UK tackled this problem by basing 
this decision on the product of close consultations between various 
groups of stakeholders.192 Discussions with fertility clinics and 
bioethicists in the UK, reveal that, when initially considering 
policy regarding savior siblings, lawyers, ethicists, scientists, 
sociologists, religious leaders, and law makers, were consulted.193 
These diverse stakeholders devised commonsense policy on a 
controversial topic, which ended up being acceptable to a broad 
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swath of the population.194 This allowed lay people to feel that the 
government was appropriately balancing the welfare of children 
(both saviors and sick siblings), as well as the values of parental 
autonomy and choice.195 Those interviewed suggested that the 
interdisciplinary nature of the committees was a major factor that 
allowed regulation to be promulgated, even when no national 
consensus existed.196  
To give the regulation teeth, the HFEA provides for 
enforcement of these rules by requiring clinics to apply for a new 
license for every new genetic disease that they would like to test 
an embryo for.197 This not only allows regulators to monitor clinics 
that perform IVF,198
 
but also enables regulation of embryo-
centered research and PGD.199 The law is given force by attaching 
criminal liability to any person who knowingly or recklessly 
provides false or misleading information to obtain a license.200 
Punishments for such violations of the Act range from a fine to 
imprisonment for up to two years.201 
Such regulation provides clear guidelines while making it 
easier to study, and control, the use of savior siblings.202 It also 
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raises difficult questions about the role of governments in the 
birthing and family decisions of their citizens. While there exists 
genuine dispute as to whether it is fair to leave such important and 
contested questions in the hands of legislators and regulators, 
especially when there are no clear or universally accepted answers 
regarding these difficult questions, the interdisciplinary approach 
to creating the regulation helped build public approval.  
VI. Conclusions and Recommendations 
The close regulation of savior siblings in the UK offers a stark 
contrast to the situation in the U.S.203 In the U.S., the relative 
novelty of the procedure, its rarity, the lack of governmental 
consideration and regulation, and the divergence in opinions 
regarding the fundamental ethical questions that surround it, help 
explain why the issue of savior siblings has remained largely in the 
shadows, unexamined by the government, or the public at large.204 
Despite this general disregard, certain commonsense steps could 
be taken to better understand and deal with the unique ethical 
dilemmas surrounding savior siblings. 
A. The U.S. Can Learn from the Regulatory Framework in the UK 
The UK has demonstrated that meaningful regulation 
regarding savior siblings is possible, without restricting other 
values, such as parental and familial autonomy and dignity, even 
in a diverse, pluralistic society, where individuals may not agree 
with each other.205 The U.S. should learn from this example, and 
seek to emulate it, to the extent feasible. As discussed, the need for 
regulation in the U.S. is pressing, given that important ethical 
decisions regarding savior siblings are currently left to the 
                                                                                                     
 203. See id. (“This stands in stark contrast to other countries, particularly 
England, France, and Australia, where a regulatory framework for the use of 
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discretion of individual parents and health care providers.206 
Indeed, given the lack of regulation in the U.S., the only true 
barrier for access is the policies of the particular clinic selected. 
This means that adequately resourced parents are able to select 
clinics that allow whatever procedures they desire.207  
The absence of regulation in the U.S. creates a number of 
particularly problematic scenarios for savior siblings. First, it 
allows potential harm to savior siblings, by not requiring that 
savior children are only utilized in specific scenarios.208 Without 
regulation, it is possible that saviors will be utilized for some of the 
more problematic scenarios discussed above, such as for more 
invasive donations, or to serve as donors to non-immediate family 
members. Second, in the absence of regulation, it is difficult to 
monitor the long-term outcomes for savior children, to ensure that 
they are respected and cared for, and do not face lifetime burdens 
due to their biology or status. Indeed, savior children issues can go 
unnoticed, as there is no central monitoring system. Even the most 
ardent defenders of a free-market system can understand the 
desire for some form of regulation, in order to protect the welfare 
of these children, who are especially vulnerable.  
Governmental regulation, informed by legislative guidance, is 
therefore necessary, both to develop workable policy, and to 
identify, document, and ameliorate current harms. While courts 
have certain checks on these outcomes, the need for a parent (or 
child) to bring an actual suit, as well as the uncertainty and 
subjectivity inherent in the current judicial standards, mean that 
courts are not an ideal mechanism to regulate this kind of practice. 
The lack of regulation also creates a situation where, given the 
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great variety of state law and cultural attitudes towards a practice 
like savior siblings, similarly situated individuals in different 
geographic contexts may have vastly different outcomes and 
access.209 Indigent individuals in states with few IVF clinics may 
find themselves unable to undertake desired procedures, because 
they cannot access clinics with policies that permit the creation of 
savior children.210 This creates harm if those individuals have 
children suffering rare genetic diseases, where a savior sibling may 
be the only viable option.211 Conversely, rich individuals are able 
to “shop around” skirting any local clinic policy by traveling to 
whichever clinic is willing to perform the desired procedure.212  
This is not to say that there will not be challenges. The lack of 
direct governmental involvement in healthcare, and IVF, will 
make it difficult for the government to begin the arduous task of 
carving out a regulatory space. The question of whether any 
potential regulation should be left to individual States will be a 
difficult one and is beyond the scope of this Article. Additionally, it 
will be difficult to truly ascertain parental motive in many 
instances of assisted reproduction, as parents could easily obscure 
the true motive behind seeking IVF and PGD, to skirt any formal 
regulation regarding savior children.  
Current lack of consensus on the controversial issues related 
to birth and pediatric donation significantly complicates any 
national push on this issue.213 Given the general political gridlock 
and the specific divisiveness of issues associated with 
reproduction, it is difficult to imagine politicians working together 
to put forth a truly bi-partisan regulatory scheme. As the UK has 
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demonstrated, it is essential that any regulation reflect the input 
of many diverse stakeholders (from doctors, to bioethicists, to 
lawyers, to disability rights advocates, to clergy, to sociologists) to 
ensure that the broad range of views on this issue are addressed 
and respected.214 While no regulatory framework will please 
everyone, this should not be the goal, especially for a novel 
procedure where cultural and scientific attitudes are still evolving. 
However, by consulting interdisciplinary stakeholders from a 
variety of political and religious affiliations regulators can put 
forth the best possible plan, for the unique situation in the U.S.  
B. Research 
Efforts to advance a discussion on savior siblings are 
hampered by the lack of robust data on this issue. We do not know 
what the true effects, if any, are of the decision to have a savior 
sibling on the ill child, the savior sibling, or the family dynamic. To 
properly consider this dilemma, researchers must focus on these 
questions and begin to gather data regarding savior siblings.215 
Such research must examine both longitudinal psychological and 
physical effects so that we can get the full picture of what it is to 
be a savior sibling. Researchers must develop a multi-factorial 
approach to examining the status of savior siblings. This will 
involve studying families prior to initiation of the process, so we 
can better understand what factors into the decision to have a 
savior sibling. Research should continue, not just throughout the 
donation process, but also in a longitudinal manner to investigate 
whether there are long-term complications or effects from being a 
savior sibling. Data must be gathered, so the fears discussed above 
can be confirmed, or disproved. Of course, ethical concerns arise 
when gathering large sets of data, especially if the data reveals 
potentially sensitive health information, or puts individuals at risk 
for harm.216 However, I am confident that, with proper planning 
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and consideration, research into savior siblings can be designed 
and conducted in an ethical manor. 
Because this is a rare situation and not many savior siblings 
currently exist or are created annually, it will take a long time to 
generate statistically valid results. Although the population size 
places a burden on getting useful information, it is likely that the 
demand for this procedure will only increase in coming years. As 
demand grows, there will be increased attention paid to savior 
siblings, which will allow more robust research. Since no one 
institution is likely to have significant numbers of subjects, 
cooperative inter-institutional (or NIH) databases will be 
important for data collection. Such efforts will ultimately provide 
insight into ethical qualms that are currently theoretical.  
C. Cord Banking 
Umbilical cord blood has a very high concentration of 
hematopoietic stem cells, which, as discussed above, can be 
extremely helpful in fighting a wide range of conditions.217 Most 
savior siblings are initially conceived to provide the life-saving 
cells that come from umbilical cord blood and tissue.218 If cord blood 
were more readily available, it would not be as necessary for 
parents to create a savior sibling. If an appropriate match is 
available, using banked cord blood could be preferable to creating 
savior siblings, given the difficulty, cost, and time requirements of 
the procedure. Expanding the availability of cord blood could 
create an option for families who can’t afford (financially, 
emotionally or due to the urgency of their sick child’s condition) to 
go through the savior sibling process. Thus, there are numerous 
clear benefits to cord blood banking.  
Cord blood banks function similarly to regular blood banks, 
but they are specifically for umbilical cord blood.219 The blood is 
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collected by a doctor following certain protocols and is then sent to 
a bank where it is typed, tested, and stored for future use.220 This 
information is stored, so that those in need of stem cells can be 
connected with HLA matched donors.221  
There are currently two options for cord blood banking: public 
or private.222 Public banks are free, regulated by the FDA, and the 
blood is HLA typed upon arrival.223 This allows quick action 
whenever there is a request, and allows
 
the blood to be available 
for anyone to access.224 Private cord blood banks in contrast, can 
be quite expensive, as parents pay an initial fee and a yearly 
charge for storage.225 This service means that the blood is only 
available for the family who banked it.
 
Any cord blood from a child 
who is eventually diagnosed with a genetic disease, inborn error of 
metabolism, or leukemia, will not be useful in treating that child, 
because the necessary cells will have the same mutation.226
 
 
Both public and private banking come with the benefit of 
enabling significant research, on the nature of umbilical cords, and 
the hematopoietic stem cells they contain. In order for cord blood 
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banking to offer a viable option as an approach to genetic diseases, 
many people with diverse HLA types must donate. Given that this 
current bounty is unrealized, it is understandable why twenty 
states have passed laws that support a policy requiring physicians 
to provide information to expecting parents regarding cord blood 
options with different provisions.227  
Increased cord banking can be accomplished while respecting 
the rights and autonomy of the parents who decide to donate. One 
step is requiring the primary physician of expectant parents to 
discuss the available options for banking of cord blood before the 
third trimester of pregnancy. Requiring the information be given 
prior to the third trimester acts a precaution, while giving parents 
time to consider the reasons why it makes sense to bank their cord 
blood. It is important to give parents time to make an informed 
decision regarding the practice before the birth of their child. If the 
practice of banking cord blood becomes common, the availability of 
cord blood for fighting future illnesses and research will greatly 
increase and could reduce the need for savior siblings. 
Cord blood banking is a particularly powerful tool, as 
currently, most umbilical cords are simply discarded.228 This 
means the medical community is throwing away a potentially 
powerful tool in the battle against many rare diseases and 
conditions. Furthermore, hematopoietic stem cells are free from 
the contentious debate surrounding other forms of stem cells, 
because they are harvested with no harm to any living person, 
embryo, or fetus.  
D. New Technological Advances 
As medicine and medical technology advances, the hope is that 
living donors will become less important. The best option for this 
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is through research leading to the discovery of more advanced 
therapeutics. New treatments that target and treat the underlying 
condition are always preferable to utilizing a living donor. 
Other future directions are more fraught with potential 
ethical and legal implications. Expanding our understanding and 
utilization of stem cell therapies could be another way to cure 
debilitating conditions, which presently require transplantation.229 
Other potential future approaches include the development of 
technologies like 3D Organ Printing,230 mechanical organs,231 or 
the use of cross species transplantation.232 Potentially, advances in 
human cloning could allow scientists to replicate unique biological 
material, entirely without the need for any individual, other than 
the sick person, to serve as a donor. Although these possibilities 
raise significant ethical issues in their own right, they could make 
the need for a savior sibling obsolete. 
E. Final Thoughts 
Few topics raise as many ethical concerns as does the debate 
over the acceptability of savior siblings. Indeed, the issue of savior 
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siblings seems to be an almost perfect storm, where values of 
autonomy, consent, familial rights, and medical technology, 
intersect in uncertain, and potentially problematic, ways.  
It is important to remember that, in most cases, savior siblings 
allow a sick child to extend their life, free from illness. This has 
untold positive consequences, not just for the child, but for the 
whole family unit. When considering the ethical conundrums, the 
saving of a child’s life must be given weight in any ethical analysis. 
Of course, we cannot turn a blind eye towards the potential for 
abuse, or the ease with which this procedure could be misused, to 
rapidly move in a direction that society is not comfortable with, 
ethically or practically.  
While the field has moved forward in the U.S. without any 
guidance or regulation, the example of the UK shows that a 
regulatory scheme is possible, and can succeed,233 even in a society 
where the underlying issues are still contested. Such regulation 
does not mean that progress will be halted, or that science and 
autonomy will be irrevocably restricted. Rather, commonsense 
regulation allows the genuine good to proceed, while protecting 
children, and ensuring, to the greatest extent possible, that undue 
harm is not occurring.  
While the aim of this Article is not to develop specific 
regulatory recommendations, a few elements stand out as 
essential to any meaningful effort to allay concerns that the issue 
of savior siblings will quickly devolve into unethical directions. 
First, it makes fundamental sense to limit savior siblings’ 
donations to biological material short of organs. Indeed, the issues 
of consent, harm, and autonomy, caution against allowing any 
child to serve as an organ donor at a very young age, unless they 
can persuasively demonstrate an understanding of the procedure. 
Second, restricting savior child donation to immediate family 
members can help address fears that families might make 
improper decisions regarding who can be “saved” by a savior child. 
Third, in order to ensure compliance, IVF clinics should report to 
a monitoring body, with a special filing for families who want to 
conceive, or are likely candidates to have, a savior child. This will 
help ensure that uses can be documented, and that data can be 
collected.  
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While these are preliminary suggestions, guidelines such as 
these, if adopted, monitored, and enforced, can prevent the 
situation from advancing in a more troubling direction. 
Furthermore, regulatory efforts will begin to standardize care and 
practice availability, so that different clinics do not offer wildly 
different options to similarly situated individuals. Guidelines will 
also allow uniform data to be gathered, permitting meaningful 
assessment of savior siblings in the United States.  
There is no question that savior siblings touch on a wide range 
of difficult topics, from cultural and social attitudes about sickness, 
birth, and family, to deeply held beliefs about medical technology, 
the role of family, and tissue donation. Silence on the matter will 
not lead to resolution. Efforts such as those discussed above, can 
begin to change the situation of savior siblings in the United 
States, so that the field can ethically proceed in a manner that 
respects and protects savior siblings and their families.  
